IL2 and amyotrophic lateral sclerosis: Ehrhart et al. proposed that IL-2 may have reduced involvement in the initial stages of ALS, but, over a 6-month natural disease progression, IL-2 levels decreased significantly compared with those in healthy controls, indicating a dynamic relationship between IL-2 and disease stages [39].